Meggle’s first micronised inhaler excipient
Tweet
InhaLac® 500 is Meggle Excipients & Technology’s first micronized inhaler excipient.
This inhalation grade lactose exhibits extremely small particles (with 90 % of the particles being smaller than 10 µm (x50 ≤ 5 µm)). In combination with the high quality and safety it will meet your individual dry powder inhalation formulation requirements.
BENEFITS
Very small particle size with 90 % of the particles smaller than 10 µm |
Micronized material with high cohesive properties |
Similar size range as API |
Versatile application, e.g. as fines or as co-agglomerate |
Retest after one year |
To learn more: MEGGLE